AbioCor was a total artificial heart (TAH) developed by the Massachusetts-based company AbioMed. It was fully implantable within a patient, due to a combination of advances in miniaturization, biosensors, plastics and energy transfer. The AbioCor ran on a rechargeable source of power. The internal battery was charged by a transcutaneous energy transmission (TET) system, meaning that no wires or tubes penetrated the skin, reducing the risk of infection. However, because of its size, this heart was only compatible with men who had a large frame. It had a product life expectancy of 18 months.[1][2][3][4][5]
AbioCor was surgically introduced into 15 total patients, 14 of them during a clinical trial and one after FDA approval. However, due to insufficient evidence of its efficacy, AbioMed abandoned further development of the product.[6][7][8]
^"National Medical Policy - NMP188" (PDF). HealthNet. September 2015. p. 17. Retrieved March 15, 2016.
^"Medical Policy Manual - Policy No: 52" (PDF). Regence. December 2015. p. 22. Retrieved March 15, 2016.
^"Heart Assist Devices - AbioCor Implantable". Texas Heart Institute. Archived from the original on March 7, 2016. Retrieved March 15, 2016.
^"Product Details". AbioMed. 2007. Archived from the original on May 21, 2007. Retrieved March 15, 2016.
^Dowling, R.D.; Etoch, S.W.; Stevens, K.A.; Johnson, A.C.; Gray Jr., L.A. (2001). "Current status of the AbioCor implantable replacement heart". The Annals of Thoracic Surgery. 71 (3): S147–S149. doi:10.1016/S0003-4975(00)02615-1. PMID 11265850.
^Leprince, P. (October 6, 2015). "Total artificial heart: What's new?" (PDF). Daily News - EACTS. European Association for Cardio-Thoracic Surgery. p. 7. Archived from the original (PDF) on March 15, 2016. Retrieved March 15, 2016.
^Palomino, J. (November 4, 2015). Lopatto, E.; Zelenko, M. (eds.). "The Heart is Just a Pump: Inside the 50-year quest to build a mechanical organ". The Verge. Vox Media, Inc. Retrieved March 15, 2016.
^"7 Things About Artificial Hearts That You Should Know". SynCardia Systems, Inc. September 12, 2014. Retrieved March 15, 2016.
AbioCor was a total artificial heart (TAH) developed by the Massachusetts-based company AbioMed. It was fully implantable within a patient, due to a combination...
technology and roller screw developed at Penn State, AbioMed designed a smaller, more stable heart, the AbioCor II. This pump, which should be implantable in...
AbioCor became the first artificial heart successfully implanted in a patient, where it pumped more than 20 million times. Fourteen of the AbioCor devices...
humanitarian. He is noted for founding Abiomed, the company that developed AbioCor, the first fully implantable artificial heart. Lederman was born in Bogota...
continuous rule by the Partido Revolucionario Institucional. 2001 – The AbioCor self-contained artificial heart is first implanted. 2002 – Steve Fossett...
approved by the FDA. 2001. The first self-contained artificial heart, AbioCor. 2001. The first remote surgery, using the ZEUS robotic surgical system...
world's first recipient of a fully self-contained artificial heart, called AbioCor. The operation took place on July 2, 2001. He survived for 151 days without...
thus the pulmonary and systemic flow. Some of the current TAHs include AbioCor, an FDA-approved device that comprises two artificial ventricles and their...
and Robert D. Dowling, performed the world's first implantation of the AbioCor Implantable Replacement Heart on July 2, in a seven-hour procedure at Jewish...
currently under development by Abiomed, Inc. and is referred to as the AbioCor II device. In addition, Rosenberg led the team that developed the Arrow...
Global Information